Beam Wealth Advisors, Inc. Merck & Co., Inc. Transaction History

Beam Wealth Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$113.24 - $131.95 $14,268 - $16,625	126 Added 4.48%	2,939 $387,000
Q4 2023 Jan 30, 2024	BUY	$100.18 - $109.02 $2,805 - $3,052	28 Added 1.01%	2,813 $306,000
Q3 2023 Oct 26, 2023	BUY	$102.95 - $114.33 $21,825 - $24,237	212 Added 8.24%	2,785 $286,000
Q2 2023 Jul 26, 2023	BUY	$108.61 - $118.38 $61,256 - $66,766	564 Added 28.07%	2,573 $296,000
Q1 2023 Apr 26, 2023	SELL	$102.94 - $114.86 $1,544 - $1,722	-15 Reduced 0.74%	2,009 $213,000
Q4 2022 Jan 20, 2023	BUY	$87.44 - $112.11 $176,978 - $226,910	2,024 New	2,024 $0
Q4 2021 Jan 14, 2022	SELL	$72.28 - $90.54 $214,743 - $268,994	-2,971 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$71.68 - $78.83 $212,961 - $234,203	2,971 New	2,971 $223,000
Q1 2020 Apr 08, 2020	SELL	$63.36 - $87.82 $167,016 - $231,493	-2,636 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $204,500 - $230,755	2,636 New	2,636 $240,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Beam Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Beam Wealth Advisors, Inc. with notifications on news.